Latest Insider Transactions at Mei Pharma, Inc. (MEIP)
This section provides a real-time view of insider transactions for Mei Pharma, Inc. (MEIP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEI Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEI Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2024
|
Steven D Wood |
BUY
Grant, award, or other acquisition
|
Direct |
3,100
+41.56%
|
$9,300
$3.17 P/Share
|
|
May 16
2024
|
James P Flynn |
BUY
Grant, award, or other acquisition
|
Direct |
7,900
+50.0%
|
$23,700
$3.16 P/Share
|
|
Oct 20
2023
|
Funicular Funds, LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
120,600
+16.47%
|
$844,200
$7.0 P/Share
|
|
Oct 20
2023
|
Anson Funds Management LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
179,000
+7.55%
|
$1,253,000
$7.0 P/Share
|
|
Oct 11
2023
|
Funicular Funds, LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
30,000
+5.76%
|
$210,000
$7.0 P/Share
|
|
Oct 11
2023
|
Anson Funds Management LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
50,000
+2.66%
|
$350,000
$7.0 P/Share
|
|
Sep 22
2023
|
Funicular Funds, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,040
+6.5%
|
$192,240
$6.85 P/Share
|
|
Sep 22
2023
|
Anson Funds Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,060
+5.27%
|
$288,360
$6.85 P/Share
|
|
Sep 21
2023
|
Anson Funds Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
33,600
+3.95%
|
$201,600
$6.46 P/Share
|
|
Sep 21
2023
|
Funicular Funds, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,400
+4.96%
|
$134,400
$6.46 P/Share
|
|
Sep 20
2023
|
Anson Funds Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
120,000
+13.3%
|
$720,000
$6.01 P/Share
|
|
Sep 20
2023
|
Funicular Funds, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+16.45%
|
$480,000
$6.01 P/Share
|
|
Feb 28
2023
|
Charles V. Baltic Iii |
BUY
Open market or private purchase
|
Direct |
81,500
+43.52%
|
$0
$0.22 P/Share
|
|
Jul 05
2022
|
Richard G Ghalie Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,196
-22.08%
|
$0
$0.54 P/Share
|
|
Jul 02
2021
|
Daniel P Phd Gold |
SELL
Payment of exercise price or tax liability
|
Direct |
41,320
-9.01%
|
$82,640
$2.94 P/Share
|
|
Jul 02
2021
|
David M Urso President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,825
-33.5%
|
$49,650
$2.94 P/Share
|
|
May 25
2021
|
Daniel P Phd Gold |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.08%
|
$10,000
$2.52 P/Share
|
|
Feb 23
2021
|
Frederick W Driscoll |
SELL
Open market or private sale
|
Direct |
25,000
-40.0%
|
$100,000
$4.03 P/Share
|